Background: Youth with sickle cell disease (SCD) are at risk for recurrent pain and depressive symptoms, both of which contribute to poorer health outcomes. Furthermore, youth and family coping with child pain, including pain catastrophizing, is known to be associated with poorer psychosocial adjustment and greater functional disability among youth with SCD. In particular, child catastrophizing about pain and parent catastrophizing about their child's pain have been linked to increased pain and depressive symptoms in youth with chronic pain conditions. Despite this, the impact of child and parent pain catastrophizing on depressive symptoms remains unexplored in pediatric SCD.
about pain) is a key predictor of pain chronicity and functional disability. 14, 15 Moreover, pain catastrophizing has been associated with enhanced pain perception and intensity, [15] [16] [17] greater functional impairment, [15] [16] [17] [18] increased healthcare utilization, 19 and heightened reports of emotional distress 19, 20 and depressive symptoms 8, 17, 18 among youth with chronic pain including SCD. In particular, youth with frequent or chronic SCD pain report higher levels of pain catastrophizing, depressive symptoms, and functional impairment than patients without recurrent pain. 1 Although it is clear that pain frequency is one factor that contributes to pain catastrophizing and depression in pediatric SCD, parents' mental health and coping with their child's disease can also exacerbate child SCD pain and emotional problems. 2, 13, 19 Parent catastrophizing about their child's pain has been associated with passive coping among youth, 21 increased child-reported pain and catastrophic thinking, 22 functional limitations, 2,21,23 school avoidance, 24 and depressive symptoms. 23 Consistent with findings from other pediatric pain populations, 23 emerging evidence also suggests that this complex interaction between parent and child pain catastrophizing is an important predictor of child functioning with recurrent SCD pain. 2 Among youth with recurrent SCD pain, higher levels of parent catastrophizing and incongruence between child and parent pain catastrophizing have been linked to poorer functional outcomes. 2 Although this link between pain catastrophizing and functional limitations has been widely supported, 2, 18, 21, 23 no research to date has explored the impact of parent and child pain catastrophizing on child depressive symptoms in pediatric SCD.
Even among families without chronic health conditions, children of parents with depression or anxiety are at increased risk for internalizing symptoms, including elevated rates of depression. [25] [26] [27] [28] In addition to underlying genetics that may predispose children to develop depression, parents' expressed negative affect and behavior along with adverse environmental events and parent-child interactions can further contribute to child risk for clinical depression. 29 Although child pain may partially contribute to depressive symptoms in youth with SCD, underlying family characteristics, such as parent anxiety or coping with child pain, may also increase youth's risk and susceptibility to clinically elevated depressive symptoms. Given the common comorbid presentation of pediatric SCD, chronic pain, and depressed mood, 1,9 it remains important to clarify the extent to which child and parent patterns of catastrophic thinking may differentially contribute to depressive symptoms.
The current study evaluated the predictive value of child and parent pain catastrophizing on depressive symptoms in youth with SCD.
The primary aim of the study examined the impact of child and parent pain catastrophizing on child depressive symptoms. Given the effect of modifiable, cognitive, and behavioral processes on depressive symptomatology, it was hypothesized that both child and parent pain catastrophizing would significantly predict youth depressive symptoms. 1, 8, 17, 18, 23 Additionally, it was expected that children with clinically elevated depressive symptoms and their parents would report higher levels of pain catastrophizing than youth without clinically elevated depressive symptoms and their parents. 1 
METHODS

Recruitment
A convenience sample of 100 youth with SCD (aged 8-18) and their parents was recruited from an urban pediatric medical center during comprehensive sickle cell clinic visits. Participants were recruited across three campus locations of a southeastern children's hospital between March 2014 and March 2015. Youth with a confirmed medical diagnosis of SCD were eligible for the study; however, non-English speaking families and/or youth or parents with significant, cognitive, or developmental disabilities (e.g., overt stroke history, severe cognitive impairment) based on documentation in the medical chart or by parent or physician report were excluded from participation. Recruitment targeted youth with SCD who had experienced any disease-related pain over the past 30 days. Furthermore, a subset of pain-free patients with SCD (i.e., reporting no disease-related pain over the past 30 days) was also recruited in order to capture the full range of pain frequency. 
Measures
2.2.1
Children's Depression Inventory-2 (CDI-2; self-report) 30 The CDI-2 is a well-established, 24-item self-report measure of youth depressive symptoms. Consistent with CDI-2 guidelines, 5 a cutoff score of 14 or greater on the CDI-2 indicates clinically elevated depressive symptoms (score range: 0-52), with scores ranging in severity from none/minimal (<10), mild (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , moderate (20) (21) (22) (23) (24) (25) (26) (27) (28) , or severe (>28). The CDI-2 has strong psychometric properties and is frequently used in pediatric disease populations, including youth with SCD and chronic pain. 8, 20 Internal reliability for the current sample was 0.85.
2.2.2
Pain Catastrophizing Scale, Child Report (PCS-C), Parent Report (PCS-P)
17,22
The PCS is a 13-item, Likert-scale questionnaire that measures child and parent beliefs and perceptions of child pain (e.g., "When I am in pain, there is nothing I can do to stop the pain" or "When I am in pain, I worry all the time about whether the pain will end"). Items are rated on a 5-point Likert scale (0 = not at all to 4 = extremely) and grouped into the three subscales, including rumination (four items; range: 0-16), magnification (three items; range: 0-12), and helplessness (six items; range: 0-24). Items are summed to obtain the subscale and total score values, with higher scores indicating greater levels of pain catastrophizing (total range: 0-52). The PCS-C and PCS-P have been used frequently in pediatric chronic pain research and well validated in samples of youth with chronic pain and their parents. 17, 18, 22 Internal reliabilities for the current sample were 0.92 for the PCS-C and 0.90 for the PCS-P.
Pain characteristics
Youth reported their pain frequency (i.e., number of pain days within the past month), pain duration (i.e., how long they had experienced pain at this level of frequency), and average pain intensity over the past 2 weeks (i.e., using a numeric rating scale with "0 ″ indicating no pain and "10 ″ representing the worst possible pain). Informed by diagnostic guidelines for chronic SCD pain, 9 
Demographic and disease characteristics
Demographic characteristics (e.g., gender, race/ethnicity, age) were collected via parent report on a demographics form, while disease/medical characteristics (e.g., SCD genotype) were obtained via retrospective chart review.
Statistical analyses
All statistical analyses were performed using SPSS, version 24. There was no missing data for the primary predictor or outcome variables.
Descriptive statistics were used to determine whether the data met the underlying assumptions of the proposed analytic procedures (e.g., normality, multicollinearity) and describe demographic, psychosocial, and medical characteristics of the sample (i.e., child or parent age, gender, SCD type, family income). Additionally, Pearson's correlations and analysis of variance (ANOVAs) explored potential covariates of the primary outcome variable. Hierarchical linear regression explored the relative contribution of child and parent pain catastrophizing on child depressive symptoms while controlling for pain frequency. The sample was divided into two groups-youth with clinically elevated depressive symptoms (CDI-2 ≥14) and those without elevated depressive symptoms (CDI-2 <14)-for analyses of covariance (ANCOVAs) to explore between-group differences on parent and child pain catastrophizing while controlling for pain frequency. Follow-up multivariate analyses of covariance (MANCOVAs) were used to examine between-group differences across parent and child pain catastrophizing subscales (rumination, magnification, helplessness) when adjusting for pain frequency.
RESULTS
Sample characteristics
The sample was generally representative of the pediatric sickle cell population. 31 Of youth and parents approached for enrollment, only three children were deemed ineligible due to significant cognitive Annual household income a <$10,000 22 (24) 4 (17) 18 (26) $10,000-20,000 17 (18) 4 (17) 13 (18) $20,001-30,000 8 (8) 3 (13) 5 (7) $30,001-50,000 22 (24) 6 (26) 16 (23) $50,001-75,000 12 (13) 5 (22) relationships between child depressive symptoms, parent catastrophizing about pain, and child pain catastrophizing (see Table 2 for intercorrelations between primary outcome variables). While a significant, positive correlation emerged between child depressive symptoms and average pain intensity (r = 0.435, P < 0.001), this relationship was not significant after controlling for pain frequency (r = 0.173, P = 0.087).
Therefore, pain frequency was maintained as the primary covariate.
Catastrophizing as predictors of child depressive symptoms
Hierarchical linear regression tested the relative contribution of child and parent pain catastrophizing on child depressive symptoms when adjusting for pain frequency. The overall model (i.e., pain frequency, child and parent pain catastrophizing) accounted for 35.9% of the variance in child depressive symptoms, F (3, 96) = 17.94, P < 0.001. After controlling for pain frequency (R 2 = 0.252), child and parent pain catastrophizing accounted for 10.7% of variance in child depressive symptoms, F∆ (2, 96) = 8.04, P < 0.01. Only pain frequency ( = 0.399, P < 0.001) and parent pain catastrophizing ( = 0.238, P < 0.05) were unique predictors of depressive symptoms (see Table 3 for a full summary of hierarchical regression analyses).
Differences in pain catastrophizing across child depressive groups
The sample was divided into groups of youth with clinically elevated depressive symptoms (CDI-2 ≥14) and those without elevated depressive symptoms (CDI-2 <14), revealing that 27% of youth reported clinically elevated symptoms of depression. Of youth presenting with clinically elevated depressed symptoms, pain was classified as either chronic (63%) or episodic (37%) in frequency. ANCOVA analyses adjusting for pain frequency revealed significant between-group
TA B L E 3 Catastrophic thinking predicts child depressive symptoms in youth with sickle cell disease
Step predictor
Step 1 Results of hierarchical regression analyses including standardized ( ) and unstandardized (B) beta weights for predictor variables. * P < 0.05; ** P < 0.01; *** P < 0.001. By contrast, no significant differences emerged on parent rumination or magnification subscales. There were no significant group differences across child rumination, magnification, or helplessness subscales, F (3, 95) = 1.82, P = 0.148; see Table 4 for a full summary of MANCOVA results. and their parents alike, exhibiting negative or exaggerated thoughts about child pain (i.e., pain catastrophizing) has been linked to greater pain intensity, functional impairment, and depressive symptoms. [15] [16] [17] [18] When parents catastrophize about their child's pain, they are modeling a negative style of thinking that may perpetuate catastrophic thinking among youth themselves. 33 By increasing child attention to pain and other negative stimuli through catastrophizing, parents may unintentionally contribute to their child's pain experience, emotional distress, and hopeless feelings, thereby, elevating the risk for depressive symptoms.
TA B L E 4 Differences between child and parent report of child pain catastrophizing controlling for pain frequency
Parent pain catastrophizing is thought to produce downstream effects upon cognitive-behavioral patterns in both children and parents. 33 As such, parents of youth with recurrent and chronic pain appear to engage in increased anxious thinking about their ability to effectively manage their child's pain. In fact, both parent pain catastrophizing and protective parenting behaviors have been associated with greater levels of pain perception and increased functional impairment among youth with chronic pain. 22, 23, 34, 35 This is in line with experimental studies of children's responses to laboratory-induced pain, which have shown that parents' engagement in pain-promoting behaviors (e.g., attending to their child's pain) results in lower pain tolerance and increased pain intensity among healthy children. 36 Moreover pain, and emotional distress. 33, 39 Importantly, parent education and training in behavioral pain management represents a foundational element of evidence-based, cognitive-behavioral therapy for pediatric pain, which is known to reduce child pain perception and emotional distress, anxiety, and paininduced behaviors. 39 A primary aspect of parent training guidelines are rooted in teaching parents to encourage participation in functional activities, even in the context of pain (e.g., school attendance), while shifting the family attentional focus away from the child's pain and toward their ability to cope and function with pain. 39 In light of research evidence supporting a trajectory in which functional improvements may precede pain control, parent training remains a critical component of chronic pain management for children and adolescents. 40 Additionally, improving upon the quality of parent-child communication of pain management needs and reducing the focus and attention on pain, has been shown to improve child pain management. 39, 41 Additional behavioral treatments, such as acceptance and commitment therapy, promote psychological acceptance that pain may continue to be a part of life when treating youth with SCD and their families. This framework is gaining efficacy and aims to increase youth's tolerance and acceptance of pain while promoting application of pain management strategies in order to enhance engagement in valued activities and increase functioning. 42, 43 It is important to highlight that SCD pain is often indicative of the underlying disease process that can persist regardless of treatment or chronic pain status; therefore, some evidence-based behavioral treatments for pain that are effective for other pain conditions may need to be tailored to meet the unique needs and pain phenotype of SCD to improve effectiveness.
It remains important to note that other caregiver and family factors, including parental anxiety, depression, and chronic pain, may contribute to this relation between parent pain catastrophizing and child depressive symptoms. Even among parents and children without chronic pain or other health conditions, parent emotional distress and depression represent an independent risk factor for adverse child outcomes, including poorer mental health functioning and increased likelihood for youth depression. [26] [27] [28] [29] 44 Theoretical models explaining this link highlight the impact of genetic, neurobiological, and social-behavioral factors including parental affect and behavior, parent-child interactions, and the family environment. 29 Within pediatric SCD, parent anxiety and ability to cope with their child's pain has been directly linked to youth emotional adjustment and pain management. 19, 32 It is also important to consider the likeliness of parents' own experience of SCD and their increased risk for chronic pain, and clinical depression and anxiety, 9,45 which may further contribute to depressive symptoms or maladaptive coping behaviors for their children. Accordingly, further research is needed in order to clarify the mechanism by which parent pain catastrophizing and other predisposing caregiver characteristics might account for depressed mood in pediatric SCD.
The current findings must be understood in the context of study limitations, which included use of sampling procedures primarily targeting youth with recurrent or chronic SCD pain. Nevertheless, the sample was found to be generally consistent with the pediatric SCD population with regard to demographic and disease characteristics. Given the cross-sectional design of the study, causal attributions cannot be made. Longitudinal or experimental investigations of pain catastrophizing patterns and child depressive symptoms are needed to elucidate our understanding of the relation among these variables and how childhood depression in pediatric SCD may be perpetuated over time.
Additionally, considering the behavioral scope of this study, limited medical data were explored across the analyses, beyond pain characteristics. Future research might examine the impact of disease-level factors, such as fatigue or healthcare utilization, on youth functioning and child depressive symptoms. Likewise, it remains to be seen whether other caregiver variables, including underlying anxiety or depressive symptoms, might better account for or strengthen this relationship between parent pain catastrophizing and child depressive symptoms. Furthermore, while an acceptable, standardized method of pain assessment was employed (i.e., retrospective, child-reported ratings), it remains important to note that such measurements are vulnerable to recall bias, including inflated reports of pain intensity, 46 and thus, continued efforts are needed to improve upon pain assessment methodology within the field.
Despite identified limitations, these results highlight the value of depressive symptom screening within pediatric SCD, a process that can be readily incorporated into medical clinic protocol as a standard of clinical care. Given that childhood depression has been identified as a prospective risk factor for chronic SCD pain, 9 integrating childhood depression screening into routine SCD care may serve to facilitate the early identification of patients with emerging chronic pain and ensure timely receipt of evidence-based treatment for chronic pain and depression.
